Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT

Benitec Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
50.87M 2.48M 4.06M 19.77M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
87K 122K 160K 194K
Receivables
229K 55K 3K 25K
Inventory
n/a 13K 1.80 n/a
Other Current Assets
579K 1.2M 14K 15K
Total Current Assets
51.67M 3.73M 4.82M 20.61M
Property-Plant & Equipment
449K 613K 993K 577K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
536K 735K 1.15M 771K
Total Assets
52.21M 4.46M 5.97M 21.38M
Account Payables
1.35M 1.14M 422K 274K
Deferred Revenue
n/a -1.14M n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
2.68M 472K 400K 276K
Total Current Liabilities
4.92M 3.98M 2.53M 1.37M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
38K n/a n/a n/a
Total Long-Term Liabilities
38K 284K 559K n/a
Total Liabilities
4.96M 4.26M 3.09M 1.37M
Total Debt
284K 559K 811K 213K
Common Stock
1K n/a 1K 1K
Retained Earnings
-190.26M -167.89M -148.33M -130.12M
Comprehensive Income
-892K -830K -1.25M -1.46M
Shareholders Equity
47.25M 202K 2.88M 20.01M
Total Investments
n/a n/a n/a n/a